Royal Bank Of Canada Issues Pessimistic Forecast for Versigent (NYSE:VGNT) Stock Price

Posted by George Bondi on Nov 7th, 2026

Versigent (NYSE:VGNT – Get Free Report) had its target price cut by equities researchers at Royal Bank Of Canada from $53.00 to $52.00 in a research report issued on Thursday, Benzinga reports. The brokerage currently has an “outperform” rating on the stock. Royal Bank Of Canada‘s price target points to a potential upside of 27.24% from the company’s current price.

VGNT has been the subject of several other research reports. UBS Group lowered their price objective on shares of Versigent from $58.00 to $55.00 and set a “buy” rating for the company in a research report on Thursday, July 9th. Oppenheimer set a $50.00 price objective on shares of Versigent in a research report on Tuesday, July 21st. Zacks Research lowered shares of Versigent from a “hold” rating to a “strong sell” rating in a research note on Thursday, October 15th. Wells Fargo & Company increased their target price on Versigent from $48.00 to $56.00 and gave the stock an “overweight” rating in a report on Wednesday, August 5th. Finally, Deutsche Bank Aktiengesellschaft reissued a “buy” rating and issued a $54.00 price target on shares of Versigent in a research note on Wednesday, August 5th. Eleven investment analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $55.08.

Check Out Our Latest Analysis on Versigent

Versigent Stock Up 1.5%

NYSE VGNT traded up $0.59 during trading hours on Thursday, reaching $40.87. 1,027,841 shares of the company’s stock were exchanged, compared to its average volume of 691,066. The company’s 50-day moving average is $44.78 and its two-hundred day moving average is $42.68. Versigent has a one year low of $26.34 and a one year high of $50.88. The company has a debt-to-equity ratio of 7.29, a quick ratio of 1.09 and a current ratio of 1.40. The company has a market capitalization of $2.89 billion and a price-to-earnings ratio of 21.29.

Versigent (NYSE:VGNT – Get Free Report) last announced its earnings results on Wednesday, November 4th. The company reported $1.91 EPS for the quarter, topping the consensus estimate of $1.79 by $0.12. The company had revenue of $2.45 billion for the quarter, compared to analyst estimates of $2.42 billion. On average, analysts forecast that Versigent will post 7.37 EPS for the current fiscal year.

Insider Activity

In other news, Director Kevin Clark sold 47,761 shares of Versigent stock in a transaction that occurred on Thursday, October 8th. The shares were sold at an average price of $44.36, for a total value of $2,118,677.96. Following the sale, the director directly owned 27,571 shares in the company, valued at $1,223,049.56. This trade represents a 63.40% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Insiders have sold 220,000 shares of company stock valued at $10,065,848 in the last 90 days.

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the business. William Blair Investment Management LLC bought a new position in Versigent in the third quarter valued at $11,751,000. Maryland State Retirement & Pension System boosted its stake in shares of Versigent by 52.4% during the 3rd quarter. Maryland State Retirement & Pension System now owns 15,696 shares of the company’s stock worth $705,000 after buying an additional 5,399 shares during the last quarter. Ritholtz Wealth Management boosted its stake in shares of Versigent by 9.8% during the 3rd quarter. Ritholtz Wealth Management now owns 6,879 shares of the company’s stock worth $309,000 after buying an additional 616 shares during the last quarter. Jacobi Capital Management LLC acquired a new position in shares of Versigent during the 3rd quarter worth about $38,000. Finally, Illinois Municipal Retirement Fund grew its holdings in shares of Versigent by 8.9% in the 3rd quarter. Illinois Municipal Retirement Fund now owns 37,059 shares of the company’s stock valued at $1,665,000 after acquiring an additional 3,043 shares in the last quarter.

More Versigent News

Here are the key news stories impacting Versigent this week:

Positive Sentiment: Versigent reported third-quarter EPS of $1.91, above the $1.79 consensus, and revenue of $2.45 billion, topping expectations of $2.42 billion. The results provide a positive earnings catalyst. Versigent Q3 results
Positive Sentiment: TD Cowen raised its price target to $59 from $58 and maintained a Buy rating, signaling continued confidence in the shares. TD Cowen rating
Neutral Sentiment: Versigent’s CFO is scheduled to participate in an RBC Capital Markets industrials conference on November 17. The event may provide investor updates but is not itself a business announcement. Conference announcement
Negative Sentiment: Royal Bank of Canada lowered its target to $52 from $53, while retaining an Outperform rating. BNP Paribas Exane also cut its target, to $54 from $55, but reaffirmed Outperform. The modest reductions temper the otherwise positive analyst outlook. RBC target update BNP Paribas Exane rating update

About Versigent

(Get Free Report)

Versigent PLC is involved in the design, manufacturing and delivery of low and high voltage power electrical architectures. Versigent PLC is based in SCHAFFHAUSEN, Switzerland.